133 related articles for article (PubMed ID: 23303815)
21. Successful nystatin powder treatment of posttraumatic invasive Aspergillus fumigatus wound infection refractory to systemic antifungal therapy.
Volkmer E; Mathonia P; Hummel T; Deiler S; Stengele M; Mutschler W
J Trauma; 2009 Dec; 67(6):E197-201. PubMed ID: 18815576
[No Abstract] [Full Text] [Related]
22. Intracranial aspergillosis in children successfully treated with antifungal therapy and surgical intervention.
Giacchino M; Chiapello N; Riva C; Scolfaro C; Pultrone M; Valera M; Peretta P; Piglione M; Di Rosa G; Tovo PA
Pediatr Infect Dis J; 2006 Apr; 25(4):379-81. PubMed ID: 16567999
[TBL] [Abstract][Full Text] [Related]
23. Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms.
Chowdhary A; Sharma C; Hagen F; Meis JF
Future Microbiol; 2014; 9(5):697-711. PubMed ID: 24957095
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic angiogenesis.
Choksy SA; Chan P
Br J Surg; 2006 Mar; 93(3):261-3. PubMed ID: 16498583
[No Abstract] [Full Text] [Related]
25. Aspergillus fumigatus: a potentially lethal ubiquitous fungus in extremely low birthweight neonates.
Langan EA; Agarwal RP; Subudhi CP; Judge MR
Pediatr Dermatol; 2010; 27(4):403-4. PubMed ID: 20653867
[TBL] [Abstract][Full Text] [Related]
26. Heat shock protein 90 (Hsp90): A novel antifungal target against Aspergillus fumigatus.
Lamoth F; Juvvadi PR; Steinbach WJ
Crit Rev Microbiol; 2016; 42(2):310-21. PubMed ID: 25243616
[TBL] [Abstract][Full Text] [Related]
27. Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis?
Snelders E; Melchers WJ; Verweij PE
Future Microbiol; 2011 Mar; 6(3):335-47. PubMed ID: 21449843
[TBL] [Abstract][Full Text] [Related]
28. Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy.
Hope WW; Kruhlak MJ; Lyman CA; Petraitiene R; Petraitis V; Francesconi A; Kasai M; Mickiene D; Sein T; Peter J; Kelaher AM; Hughes JE; Cotton MP; Cotten CJ; Bacher J; Tripathi S; Bermudez L; Maugel TK; Zerfas PM; Wingard JR; Drusano GL; Walsh TJ
J Infect Dis; 2007 Feb; 195(3):455-66. PubMed ID: 17205486
[TBL] [Abstract][Full Text] [Related]
29. Advances against aspergillosis.
Steinbach WJ; Stevens DA; Denning DW; Moss RB
Clin Infect Dis; 2003 Oct; 37 Suppl 3():S155-6. PubMed ID: 12975750
[No Abstract] [Full Text] [Related]
30. Home Environment as a Source of Life-Threatening Azole-Resistant Aspergillus fumigatus in Immunocompromised Patients.
Lavergne RA; Chouaki T; Hagen F; Toublanc B; Dupont H; Jounieaux V; Meis JF; Morio F; Le Pape P
Clin Infect Dis; 2017 Jan; 64(1):76-78. PubMed ID: 27682064
[TBL] [Abstract][Full Text] [Related]
31. [Therapeutic angiogenesis for ischemic diseases].
Aoki M; Morishita R
Nihon Rinsho; 2006 Apr; 64(4):762-8. PubMed ID: 16613196
[TBL] [Abstract][Full Text] [Related]
32. The use of voriconazole in the treatment of Aspergillus fumigatus keratitis.
Stewart RM; Quah SA; Neal TJ; Kaye SB
Br J Ophthalmol; 2007 Aug; 91(8):1094-6. PubMed ID: 17638830
[No Abstract] [Full Text] [Related]
33. Voriconazole-Susceptible and Voriconazole-Resistant Aspergillus fumigatus Coinfection.
Kolwijck E; van der Hoeven H; de Sévaux RG; ten Oever J; Rijstenberg LL; van der Lee HA; Zoll J; Melchers WJ; Verweij PE
Am J Respir Crit Care Med; 2016 Apr; 193(8):927-9. PubMed ID: 27082535
[No Abstract] [Full Text] [Related]
34. Efficacy of ambruticin analogs in a murine model of invasive pulmonary aspergillosis.
Chiang LY; Ejzykowicz DE; Tian ZQ; Katz L; Filler SG
Antimicrob Agents Chemother; 2006 Oct; 50(10):3464-6. PubMed ID: 17005833
[TBL] [Abstract][Full Text] [Related]
35. Secretion stress and antifungal resistance: an Achilles' heel of Aspergillus fumigatus?
Richie DL; Feng X; Krishnan K; Askew DS
Med Mycol; 2011 Apr; 49 Suppl 1():S101-6. PubMed ID: 20608779
[TBL] [Abstract][Full Text] [Related]
36. Delivery of basic fibroblast growth factor using heparin-conjugated fibrin for therapeutic angiogenesis.
Yang HS; Bhang SH; Hwang JW; Kim DI; Kim BS
Tissue Eng Part A; 2010 Jun; 16(6):2113-9. PubMed ID: 20136400
[TBL] [Abstract][Full Text] [Related]
37. Synergistic effects of FGF-2 and PDGF-BB on angiogenesis and muscle regeneration in rabbit hindlimb ischemia model.
Li J; Wei Y; Liu K; Yuan C; Tang Y; Quan Q; Chen P; Wang W; Hu H; Yang L
Microvasc Res; 2010 Jul; 80(1):10-7. PubMed ID: 20045007
[TBL] [Abstract][Full Text] [Related]
38. Multidrug resistance in Aspergillus fumigatus.
Warris A; Weemaes CM; Verweij PE
N Engl J Med; 2002 Dec; 347(26):2173-4. PubMed ID: 12501236
[No Abstract] [Full Text] [Related]
39. Is angiogenesis an organizing principle in biology and medicine?
Folkman J
J Pediatr Surg; 2007 Jan; 42(1):1-11. PubMed ID: 17208533
[No Abstract] [Full Text] [Related]
40. Allergic bronchopulmonary aspergillosis and Aspergillus infection in cystic fibrosis.
Moss RB
Curr Opin Pulm Med; 2010 Nov; 16(6):598-603. PubMed ID: 20720494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
